Education
About Us
Working with TipRanks
Follow Us
Kaken Pharmaceutical Co Ltd (KKPCF)
OTHER OTC:KKPCF
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
KKPCF Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
$29.5→$30.23
Buy
15.84%
Upside
Reiterated
09/17/25
AI Generated ArticleAI Generated Article
Morgan Stanley
$41.28→$37.9
Buy
45.19%
Upside
Reiterated
05/28/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
$29.5→$30.23
Buy
15.84%
Upside
Reiterated
09/17/25
AI Generated ArticleAI Generated Article
Morgan Stanley
$41.28→$37.9
Buy
45.19%
Upside
Reiterated
05/28/25
Best Analysts Covering Kaken Pharmaceutical Co
1 Month
xxx
Success Rate
3/5 ratings generated profit
Average Return
-1.22%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of -1.22% per trade.
3 Months
xxx
Success Rate
1/5 ratings generated profit
Average Return
-3.34%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 20.00% of your transactions generating a profit, with an average return of -3.34% per trade.
1 Year
Success Rate
1/5 ratings generated profit
Average Return
-3.32%
reiterated a buy rating 7 days ago
Copying Bryce Generon's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -3.32% per trade.
2 Years
xxx
Success Rate
1/5 ratings generated profit
Average Return
-3.32%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -3.32% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KKPCF Analyst Recommendation Trends
Rating
Apr 25
May 25
Jul 25
Aug 25
Sep 25
Strong Buy
1
3
6
8
8
Buy
2
2
2
0
0
Hold
0
0
0
0
0
Sell
2
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
8
8
8
Each month's total comprises the sum of three months' worth of ratings.
KKPCF Stock Forecast FAQ
What is KKPCF’s average 12-month price target, according to analysts?
Based on analyst ratings, Kaken Pharmaceutical Co Ltd’s 12-month average price target is 30.20.
What is KKPCF’s upside potential, based on the analysts’ average price target?
Kaken Pharmaceutical Co Ltd has 15.71% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KKPCF a Buy, Sell or Hold?
Kaken Pharmaceutical Co Ltd has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Kaken Pharmaceutical Co Ltd’s price target?
The average price target for Kaken Pharmaceutical Co Ltd is 30.20. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.20 ,the lowest forecast is $30.20. The average price target represents 15.71% Increase from the current price of $26.1.
The highest analyst price target is $30.20 ,the lowest forecast is $30.20. The average price target represents 15.71% Increase from the current price of $26.1.
What do analysts say about Kaken Pharmaceutical Co Ltd?
Kaken Pharmaceutical Co Ltd’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of KKPCF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.